CN111773336A - Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof - Google Patents

Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof Download PDF

Info

Publication number
CN111773336A
CN111773336A CN202010606216.8A CN202010606216A CN111773336A CN 111773336 A CN111773336 A CN 111773336A CN 202010606216 A CN202010606216 A CN 202010606216A CN 111773336 A CN111773336 A CN 111773336A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
medicine composition
fried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010606216.8A
Other languages
Chinese (zh)
Inventor
杨珺超
王真
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Affiliated Hospital of ZCMU
Original Assignee
First Affiliated Hospital of ZCMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Affiliated Hospital of ZCMU filed Critical First Affiliated Hospital of ZCMU
Priority to CN202010606216.8A priority Critical patent/CN111773336A/en
Publication of CN111773336A publication Critical patent/CN111773336A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/346Platycodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535Perilla (beefsteak plant)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888Pinellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964Anemarrhena
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition of ephedra, apricot and stephania sinica for treating common type new coronary pneumonia, and a preparation method and an application thereof, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by mass: 5-20 parts of mix-fried herba ephedrae, 10-30 parts of almond, 10-30 parts of gypsum, 10-30 parts of rhizoma anemarrhenae, 10-30 parts of rhizoma smilacis glabrae, 10-30 parts of fresh rhizoma phragmitis, 10-30 parts of raw semen coicis, 10-30 parts of semen benincasae, 10-30 parts of peach kernel, 10-30 parts of wild buckwheat root, 10-30 parts of fried radix scutellariae, 10-30 parts of platycodon grandiflorum, 10-30 parts of ginger processed pinellia tuber, 10-30 parts of caulis perillae and 10-30 parts of sappan wood. The traditional Chinese medicine composition obviously improves respiratory symptoms and shortens the isolation time, and the traditional Chinese medicine composition is a medicine prescription selected by taking heat clearing and phlegm reducing as a treatment principle under the guidance of the theory of traditional Chinese medicine, has no obvious toxic or side effect in treatment, can be taken for a long time, and has wide application range.

Description

Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof
(I) technical field
The invention relates to a ephedra, apricot and stephania sinica diels traditional Chinese medicine composition for treating common type new coronary pneumonia and preparation and application thereof.
(II) background of the invention
Since 12 months in 2019, only six kinds of coronavirus which can infect human are known, wherein only two kinds of SARS-CoV and MERS-CoV can kill pneumonia together, and the other four kinds of HcoV-229E, HcoV-NL63, HcoV-HKU1 and HcoV-OC43 coronavirus can only cause mild respiratory tract infection. This new coronavirus pneumonia seems to cause symptoms similar to SARS, and a recent clinical study from china released by Lancet showed that 41 patients with 2019-nCoV infection who had been diagnosed in the laboratory, 1/3 needed intensive care, 6 deaths, and 5 patients with acute cardiac injury, and the latter study of concurrent epidemics reported clinical and microbiological data from six families, confirming the possibility of interpersonal spread. The situation of epidemic is severe, the propagation path is unknown at present, and no specific therapeutic drug is available, so that in view of the actual combat experience during the SARS epidemic period in 2003, the unique advantages of the traditional Chinese medicine in the epidemic prevention and treatment process need to be brought into play at present.
Respiratory tract infection caused by the respiratory tract virus has the characteristics of seasonality, epidemic, infectivity and the like, and the respiratory tract infection belongs to the category of warm diseases in traditional Chinese medicine, and can be called as exhaling according to different seasons such as wet temperature, spring temperature, wind temperature, winter temperature and the like. In thousands of years of clinical practice, ancient physicians accumulated valuable experience in the treatment of seasonal disorders. As early as in Su Wen & Ci Fang Lun, we propose to avoid its toxic pathogen. Emphasizes the idea that the pestilence needs to be prevented before the disease is caused, and inspires the epidemic prevention nowadays. The "Shanghai treatise on the clinical experience of ancient physicians in treating the acute infectious disease" Shanghai "represented by Zhang Zhongjing was recorded in the Shanghai treatise on the typhoid. The prescriptions of ephedra decoction, small bupleurum decoction, large chengqi decoction, white tiger decoction, Sini decoction and the like are always the main prescriptions for treating seasonal infectious diseases by the later-aged doctors. In the period of Song Jinyuan and in the beginning of Ming dynasty, the pestilence in China is rampant, doctors and families use the classics in the Shang Han Lun, and the doctors and the families have innovation in combination with clinical practice, thereby creating the epidemic febrile disease and making a lot of contribution which cannot be killed.
The pathogenesis of the disease is that pathogenic factors of pestilence enter from mouth to nose, firstly invade the lung, the lung qi is damaged, and the lung qi fails to clear and descend, so that cough, dispersion and descent disorder, dyspnea and tachypnea, chest distress and dyspnea occur. The middle stage of the disease is usually syndrome of accumulated dampness-heat.
Disclosure of the invention
The invention aims to provide a traditional Chinese medicine composition for treating common type neocoronary pneumonia and application thereof, under the guidance of traditional Chinese medicine theory, aiming at the pathogenesis characteristics of the common type neocoronary pneumonia, the traditional Chinese medicine composition capable of clearly improving the disease is obtained by screening traditional Chinese medicine raw materials through reasonable proportioning and synergistic effect of all medicinal materials, and the prepared traditional Chinese medicine composition can achieve the purposes of treating patients with the new type coronary pneumonia and reducing severe symptoms of the patients with mild symptoms, has no toxic or side effect, is suitable for being taken by people, and has a clear effect on treating the common type neocoronary pneumonia.
The technical scheme adopted by the invention is as follows:
the invention provides a traditional Chinese medicine composition for treating common neocoronary pneumonia, which is prepared from the following raw materials in parts by mass: 5-20 parts of mix-fried ephedra herb, 10-30 parts of almond, 10-30 parts of gypsum, 10-30 parts of rhizoma anemarrhenae, 10-30 parts of rhizoma smilacis glabrae, 10-30 parts of fresh rhizoma phragmitis, 10-30 parts of raw semen coicis, 10-30 parts of white gourd seed, 10-30 parts of peach kernel, 10-30 parts of wild buckwheat root, 10-30 parts of fried radix scutellariae, 5-30 parts of platycodon grandiflorum, 5-30 parts of rhizoma zingiberis semipinellia, 10-30 parts of caulis perillae and 10-30 parts of sappan wood.
Further, preferably, the traditional Chinese medicine composition is prepared from the following raw materials in parts by mass: 9 parts of mix-fried ephedra herb, 10 parts of almond, 30 parts of gypsum, 12 parts of rhizoma anemarrhenae, 10 parts of glabrous greenbrier rhizome, 30 parts of fresh reed rhizome, 30 parts of raw coix seed, 30 parts of white gourd seed, 12 parts of peach kernel, 30 parts of wild buckwheat root, 12 parts of fried baical skullcap root, 9 parts of platycodon root, 9 parts of ginger processed pinellia tuber, 12 parts of caulis perllae and 12 parts of sappan wood.
Further, the traditional Chinese medicine composition also comprises a pharmaceutically acceptable carrier, and is prepared into granules, decoction or oral liquid which are well known in the art.
The common traditional Chinese medicine composition for treating the Xinguan pneumonia is prepared by selecting roasted ephedra, almond, gypsum (decocted first), rhizoma anemarrhenae, rhizoma smilacis glabrae, rhizoma phragmitis (particularly preferred fresh rhizoma phragmitis), raw coix seed, wax gourd seed, peach kernel, wild buckwheat root, fried scutellaria baicalensis, platycodon grandiflorum, ginger processed pinellia ternate, caulis perllae and sappan wood to prepare active components; has the effects of pungent and cool nature, dispersing and purging, clearing lung-heat and relieving asthma, clearing lung-heat and eliminating phlegm, removing blood stasis and expelling pus.
The invention also provides a preparation method of the traditional Chinese medicine composition, which comprises the following steps: weighing mix-fried ephedra herb, almond, gypsum, rhizoma anemarrhenae, glabrous greenbrier rhizome, fresh reed rhizome, raw coix seed, white gourd seed, peach seed, wild buckwheat root, fried baical skullcap root, platycodon root, ginger processed pinellia tuber, perilla stem and sappan wood according to the formula amount, mixing, adding water which is 5 times of the total weight of the medicinal materials, soaking for 1 hour, heating and decocting for 20 minutes, boiling and filtering; and adding 3 times of water into the medicine residues, heating to boil, filtering after boiling, combining the filtrates, and concentrating until the density is 1.02-1.2 to obtain decoction.
The invention also relates to application of the traditional Chinese medicine composition in preparing a medicine for treating common neocoronary pneumonia.
The general type new coronary pneumonia of the invention: meets the diagnosis standard, has fever and respiratory tract symptoms, and has the manifestation of pneumonia in imaging.
Common type Xinguan pneumonia is characterized by internal heat transpiration and heat-induced fluid damage. Gypsum Fibrosum is used in the prescription for treating diseases due to its reasonable constitution. Gypsum, gypsum, pungent in flavor and cold in property, enters the lung and stomach meridians, pungent in property and capable of ventilating, cold in property and clearing heat, can clear heat from the muscles and muscles, and can remove qi and remove high fever. Matching with heat-clearing and detoxifying drugs, and selecting the scutellaria baicalensis and the tartarian buckwheat root which enter the lung meridian at the same time to clear and purge lung heat. Herba Ephedrae and semen Armeniacae amarum may be added for the purpose of preventing heat and clearing lung qi. The Qianjin Phragmites communis stem decoction is a moistening and descending product, with Phragmites communis root passing through and clearing the upper heat, sweet and cold in nature, clearing lung-heat and stomach-heat, and promoting the production of body fluid, and wax gourd seed is sweet and cold in nature, clearing heat and resolving phlegm, especially good at promoting diuresis and expelling pus; semen coicis is sweet, bland and slightly cold, can clear heat, discharge pus, invigorate spleen, promote diuresis, excrete dampness, and help to remove phlegm-dampness in lung; peach kernel, semen Persicae is pungent and bitter in flavor and neutral in nature, has the actions of activating blood and resolving phlegm, relieving cough and asthma, and its action of removing blood stasis and resolving phlegm is true without being lost.
Compared with the prior art, the invention has the following beneficial effects: the traditional Chinese medicine composition obviously improves respiratory symptoms and shortens the isolation time, and the traditional Chinese medicine composition is a medicine formula selected based on the principle of clearing heat and reducing phlegm under the guidance of the theory of traditional Chinese medicine, has no obvious toxic or side effect in treatment, can be taken for a long time, and has wide application range.
(IV) detailed description of the preferred embodiments
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto:
the raw materials used in the embodiment of the invention are all collected and prepared according to the 'Chinese pharmacopoeia' 2015 edition.
EXAMPLE 1 Chinese medicinal composition
1. The formula is as follows: the traditional Chinese medicine composition is prepared from the following raw materials in parts by mass: 9 parts of mix-fried ephedra herb, 10 parts of almond, 30 parts of gypsum, 12 parts of rhizoma anemarrhenae, 10 parts of glabrous greenbrier rhizome, 30 parts of fresh reed rhizome, 30 parts of raw coix seed, 30 parts of white gourd seed, 12 parts of peach kernel, 30 parts of wild buckwheat root, 12 parts of fried baical skullcap root, 9 parts of platycodon root, 9 parts of ginger processed pinellia tuber, 12 parts of caulis perllae and 12 parts of sappan wood.
2. Preparation:
weighing 9g of mix-fried ephedra herb, 10g of almond, 30g of gypsum, 12g of rhizoma anemarrhenae, 10g of glabrous greenbrier rhizome, 30g of fresh reed rhizome, 30g of raw coix seed, 30g of white gourd seed, 12g of peach seed, 30g of wild buckwheat root, 12g of fried baical skullcap root, 9g of platycodon root, 9g of ginger processed pinellia tuber, 12g of perilla stem and 12g of sappan wood according to the formula amount, adding 5 times of water by the total weight of the medicinal materials, soaking for 1 hour, heating and decocting for 20 minutes, boiling and filtering; and adding 3 times of water into the medicine residues, heating the medicine residues to boil, filtering the medicine residues after boiling, combining the filtrate, and concentrating the filtrate until the density is 1.02-1.2 to obtain decoction.
Example 2 general clinical observations of the Chinese medicinal composition of the invention for treating New coronary pneumonia
63 patients were from Wenzhou Central Hospital, Taizhou Enze Hospital, and Wenling first-person Hospital, 15, 46, and 2 patients, respectively. The research adopts a queue research method, mainly observes the case evaluation curative effect summary, and observes the condition of the patient. Dividing into a control group and an observation group according to whether the patients take the traditional Chinese medicine orally or not, naturally grouping according to the clinical treatment condition, and not limiting the number of each group.
Inclusion criteria were: firstly, a patient with the novel coronavirus pneumonia is diagnosed; ② the clinical typing belongs to the novel common type of coronavirus pneumonia; age 18-85 years old; fourthly, the informed consent is signed.
Exclusion criteria: firstly, patients with relatively serious primary diseases such as heart, lung, liver, kidney, brain, hematopoietic system and the like are combined; ② pregnant or lactating women; ③ psychiatric patients; and fourthly, the Chinese herbal medicines are participating in other clinical testers or taking other Chinese herbal medicines.
The method comprises the following steps: whether to apply the traditional Chinese medicine treatment is determined according to the will of a patient, and the traditional Chinese medicine treatment is divided into a control group and an observation group according to the application condition of the traditional Chinese medicine.
Control group: conventional western medicine treatment (refer to the fifth edition of trial run of 'diagnosis and treatment plan for pneumonia infected by novel coronavirus' issued by national Weijian Commission and national Central office).
Observation group: the decoction prepared by the method of the invention example 1 is added on the basis of western medicine treatment according to the fifth edition of diagnosis and treatment plan for pneumonia infected by novel coronavirus for patients with definite diagnosis of common type novel coronavirus pneumonia, twice a day with 100ml each time, and the treatment course is 14 days.
Observation contents and evaluation index
The observation includes the following aspects:
(1) changes of disease (body temperature, clinical manifestations, outcome, degree of disease and prognosis)
(2) Laboratory examinations (blood routine + CRP, procalcitonin, Lung CT, etc.)
Evaluation indexes are as follows:
(1) the main indexes are as follows: the disease condition is classified into
(2) Secondary indexes are as follows: pathogenic negative conversion rate and duration, and complication rate
And (3) performing data statistical analysis after the treatment course is finished:
each index and data are standardized and processed using SPSS software. All statistical tests used a two-sided test, with differences of less than or equal to 0.05 being statistically significant. The results are shown in tables 1 to 3, and the safety evaluation is shown in table 4, and only 3 of 63 patients showed abnormal liver function, intestinal dysbacteriosis, and hypokalemia, respectively. However, the above complications are closely related to the disease itself, and are not completely drug-related.
TABLE 1 improvement of major clinical symptoms
Figure BDA0002559190910000041
TABLE 2 Return to Condition
Figure BDA0002559190910000051
TABLE 3 duration of negative conversion of pathogenic nucleic acids
Figure BDA0002559190910000052

Claims (5)

1. A traditional Chinese medicine composition for treating common neocoronary pneumonia is characterized by being prepared from the following raw materials in parts by mass: 5-20 parts of mix-fried ephedra herb, 10-30 parts of almond, 10-30 parts of gypsum, 10-30 parts of rhizoma anemarrhenae, 10-30 parts of rhizoma smilacis glabrae, 10-30 parts of fresh rhizoma phragmitis, 10-30 parts of raw semen coicis, 10-30 parts of white gourd seed, 10-30 parts of peach kernel, 10-30 parts of wild buckwheat root, 10-30 parts of fried radix scutellariae, 5-30 parts of platycodon grandiflorum, 5-30 parts of ginger processed pinellia tuber, 10-30 parts of caulis perllae and 10-30 parts of sappan wood.
2. The traditional Chinese medicine composition of claim 1, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by mass: 9 parts of mix-fried ephedra herb, 10 parts of almond, 30 parts of gypsum, 12 parts of rhizoma anemarrhenae, 10 parts of glabrous greenbrier rhizome, 30 parts of fresh reed rhizome, 30 parts of raw coix seed, 30 parts of white gourd seed, 12 parts of peach kernel, 30 parts of wild buckwheat root, 12 parts of fried baical skullcap root, 9 parts of platycodon root, 9 parts of ginger processed pinellia tuber, 12 parts of caulis perllae and 12 parts of sappan wood.
3. The Chinese medicinal composition of claim 1, wherein the Chinese medicinal composition further comprises a pharmaceutically acceptable carrier, and is prepared into granules, decoction or oral liquid.
4. A method for preparing the traditional Chinese medicine composition of claim 1, which is characterized by comprising the following steps: weighing mix-fried ephedra herb, almond, gypsum, rhizoma anemarrhenae, glabrous greenbrier rhizome, fresh reed rhizome, raw coix seed, white gourd seed, peach seed, wild buckwheat root, fried baical skullcap root, platycodon root, ginger processed pinellia tuber, perilla stem and sappan wood according to the formula amount, mixing, adding water which is 5 times of the total weight of the medicinal materials, soaking for 1 hour, heating and decocting for 20 minutes, boiling and filtering; and adding 3 times of water into the medicine residues, heating to boil, filtering after boiling, combining the filtrates, and concentrating until the density is 1.02-1.2 to obtain decoction.
5. An application of the Chinese medicinal composition of claim 1 in preparing a medicament for treating common neocoronary pneumonia.
CN202010606216.8A 2020-06-29 2020-06-29 Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof Pending CN111773336A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010606216.8A CN111773336A (en) 2020-06-29 2020-06-29 Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010606216.8A CN111773336A (en) 2020-06-29 2020-06-29 Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof

Publications (1)

Publication Number Publication Date
CN111773336A true CN111773336A (en) 2020-10-16

Family

ID=72760814

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010606216.8A Pending CN111773336A (en) 2020-06-29 2020-06-29 Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN111773336A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杨珺超等: "浙江省《新型冠状病毒肺炎中医药防治推荐方案(试行第四版)》解读", 《浙江中医药大学学报》 *

Similar Documents

Publication Publication Date Title
CN112353855A (en) Application of traditional Chinese medicine composition in preparation of medicine for adjuvant therapy of novel coronavirus pneumonia
CN111388582B (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof
CN111671867B (en) Novel traditional Chinese medicine composition for treating mild coronary virus pneumonia cough
WO2022036779A1 (en) Huashibaidu granule, preparation method therefor and anti-viral drug
KR20040012447A (en) Herbal pharmaceutical composition for treatment of hiv/aids patients
CN103341092B (en) Preparation method of powder for treating atrophic vaginitis
CN111358905A (en) Traditional Chinese medicine mixture for treating pneumonia and preparation method thereof
CN103301353B (en) Pharmaceutical composition for treating atrophic vaginitis
CN103285284B (en) Medical composition for treating senile vaginitis
CN111773336A (en) Traditional Chinese medicine composition for treating common neocoronary pneumonia and preparation and application thereof
CN104042887B (en) Compound medicine for treating pulmonary heart disease and preparation method and application thereof
CN115998824B (en) Traditional Chinese medicine composition for clearing damp and detoxicating, and preparation method and application thereof
CN105250968A (en) Traditional Chinese medicine preparation for treating asthma
CN111773302A (en) Traditional Chinese medicine composition for treating severe new coronary pneumonia and preparation and application thereof
CN111773331A (en) Traditional Chinese medicine composition for treating suspected new coronary pneumonia and preparation and application thereof
CN109771632A (en) A kind of pharmaceutical composition and its preparation method and application for treating stable phase of chronic obstructive pulmonary disease
CN114732889B (en) Traditional Chinese medicine composition and traditional Chinese medicine oral preparation for treating phlegm turbidity and lung obstruction in acute attack stage of bronchial asthma
CN113274470B (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia
CN107744583A (en) Alleviate epithelium healing inflammation, control epithelium healing anaphylactoid Chinese medicine composition, its preparation method and its application
CN112138105B (en) Traditional Chinese medicine composition for treating bronchiectasis lung-spleen qi deficiency and phlegm-damp lung blocking syndrome and application thereof
TWI840312B (en) A chinese medicinal composition and its application
CN105770455A (en) Traditional Chinese medicinal preparation for treating bronchial asthma
CN105943700A (en) Traditional Chinese medicine composition capable of tonifying kidney and relieving paralysis and preparation method and application thereof
CN105435162A (en) Traditional Chinese medicine composition for treating allergic rhinitis, preparation method and traditional Chinese medicine preparation
CN104189870A (en) Traditional Chinese medicine for treating allergic asthma

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201016

RJ01 Rejection of invention patent application after publication